223 related articles for article (PubMed ID: 28596119)
1. Alterations of M1 and M4 acetylcholine receptors in the genetically dystonic (dt
Hamann M; Plank J; Richter F; Bode C; Smiljanic S; Creed M; Nobrega JN; Richter A
Neuroscience; 2017 Aug; 357():84-98. PubMed ID: 28596119
[TBL] [Abstract][Full Text] [Related]
2. Role of striatal NMDA receptor subunits in a model of paroxysmal dystonia.
Avchalumov Y; Sander SE; Richter F; Porath K; Hamann M; Bode C; Kirschstein T; Köhling R; Richter A
Exp Neurol; 2014 Nov; 261():677-84. PubMed ID: 25139804
[TBL] [Abstract][Full Text] [Related]
3. Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease.
Ztaou S; Maurice N; Camon J; Guiraudie-Capraz G; Kerkerian-Le Goff L; Beurrier C; Liberge M; Amalric M
J Neurosci; 2016 Aug; 36(35):9161-72. PubMed ID: 27581457
[TBL] [Abstract][Full Text] [Related]
4. Striatal and nigral muscarinic type 1 and type 4 receptors modulate levodopa-induced dyskinesia and striato-nigral pathway activation in 6-hydroxydopamine hemilesioned rats.
Brugnoli A; Pisanò CA; Morari M
Neurobiol Dis; 2020 Oct; 144():105044. PubMed ID: 32798726
[TBL] [Abstract][Full Text] [Related]
5. Effects of Muscarinic Acetylcholine m1 and m4 Receptor Blockade on Dyskinesia in the Hemi-Parkinsonian Rat.
Chambers NE; Meadows SM; Taylor A; Sheena E; Lanza K; Conti MM; Bishop C
Neuroscience; 2019 Jun; 409():180-194. PubMed ID: 31029732
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological and autoradiographic studies on the pathophysiological role of GABA(B) receptors in the dystonic hamster: pronounced antidystonic effects of baclofen after striatal injections.
Sander SE; Richter F; Raymond R; Diwan M; Lange N; Nobrega JN; Richter A
Neuroscience; 2009 Aug; 162(2):423-30. PubMed ID: 19427369
[TBL] [Abstract][Full Text] [Related]
7. Differential involvement of M1-type and M4-type muscarinic cholinergic receptors in the dorsomedial striatum in task switching.
McCool MF; Patel S; Talati R; Ragozzino ME
Neurobiol Learn Mem; 2008 Feb; 89(2):114-24. PubMed ID: 17709264
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of basal and amphetamine-stimulated extracellular signal-regulated kinase (ERK) phosphorylation in the rat forebrain by muscarinic acetylcholine M4 receptors.
He N; Mao LM; Sturich AW; Jin DZ; Wang JQ
Brain Res; 2018 Jun; 1688():103-112. PubMed ID: 29577888
[TBL] [Abstract][Full Text] [Related]
9. Effects of muscarinic receptor antagonists on cocaine discrimination in wild-type mice and in muscarinic receptor M
Joseph L; Thomsen M
Behav Brain Res; 2017 Jun; 329():75-83. PubMed ID: 28442355
[TBL] [Abstract][Full Text] [Related]
10. Effects of pharmacological entopeduncular manipulations on idiopathic dystonia in the dt(sz) mutant hamster.
Hamann M; Sander SE; Kreil A; Richter A
J Neural Transm (Vienna); 2010 Jun; 117(6):747-57. PubMed ID: 20454986
[TBL] [Abstract][Full Text] [Related]
11. Effects of striatal injections of GABA(A) receptor agonists and antagonists in a genetic animal model of paroxysmal dystonia.
Hamann M; Richter A
Eur J Pharmacol; 2002 May; 443(1-3):59-70. PubMed ID: 12044793
[TBL] [Abstract][Full Text] [Related]
12. Evidence for striatal dopaminergic overactivity in paroxysmal dystonia indicated by microinjections in a genetic rodent model.
Rehders JH; Löscher W; Richter A
Neuroscience; 2000; 97(2):267-77. PubMed ID: 10799758
[TBL] [Abstract][Full Text] [Related]
13. Muscarinic acetylcholine M
Liu L; Huang Y; Huang Q; Zhao Z; Yu J; Wang L
Neuropharmacology; 2017 May; 117():376-386. PubMed ID: 28257887
[TBL] [Abstract][Full Text] [Related]
14. Effects of intrastriatal injections of glutamate receptor antagonists on the severity of paroxysmal dystonia in the dtsz mutant.
Sander SE; Richter A
Eur J Pharmacol; 2007 Jun; 563(1-3):102-8. PubMed ID: 17349621
[TBL] [Abstract][Full Text] [Related]
15. The muscarinic receptor antagonist tropicamide suppresses tremulous jaw movements in a rodent model of parkinsonian tremor: possible role of M4 receptors.
Betz AJ; McLaughlin PJ; Burgos M; Weber SM; Salamone JD
Psychopharmacology (Berl); 2007 Oct; 194(3):347-59. PubMed ID: 17594079
[TBL] [Abstract][Full Text] [Related]
16. Acetylcholine receptor binding and cholinergic interneuron density are unaltered in a genetic animal model of primary paroxysmal dystonia.
Hamann M; Raymond R; Varughesi S; Nobrega JN; Richter A
Brain Res; 2006 Jul; 1099(1):176-82. PubMed ID: 16764832
[TBL] [Abstract][Full Text] [Related]
17. Subtle changes in striatal muscarinic M1 and M4 receptor expression in the DYT1 knock-in mouse model of dystonia.
Richter F; Klein L; Helmschrodt C; Richter A
PLoS One; 2019; 14(12):e0226080. PubMed ID: 31805123
[TBL] [Abstract][Full Text] [Related]
18. Deficit of striatal parvalbumin-reactive GABAergic interneurons and decreased basal ganglia output in a genetic rodent model of idiopathic paroxysmal dystonia.
Gernert M; Hamann M; Bennay M; Löscher W; Richter A
J Neurosci; 2000 Sep; 20(18):7052-8. PubMed ID: 10995851
[TBL] [Abstract][Full Text] [Related]
19. Muscarinic M1, but not M4, receptor antagonism impairs divided attention in male rats.
Nicklas PR; Kiefer ML; Whalen MA; Stewart MT; Mosura DE; Bennett EM; Hawley WR; McLaughlin PJ
Pharmacol Biochem Behav; 2021 Jun; 205():173184. PubMed ID: 33836220
[TBL] [Abstract][Full Text] [Related]
20. Effects of locally administered pentylenetetrazole on nigral single unit activity and severity of dystonia in a genetic model of paroxysmal dystonia.
Fedrowitz M; Hamann M; Rehders JH; Richter A; Gernert M
J Neurosci Res; 2002 Jun; 68(5):595-603. PubMed ID: 12111849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
